Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo

Cancer Gene Therapy

Volumn 21, Issue 12, 2014, Pages 518-525

  Wyche, T P ^a   Dammalapati, A ^b   Cho, H ^a   Harrison, A D ^b   Kwon, G S ^a   Chen, H ^b   Bugni, T S ^a   Jaskula Sztul, R ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; NOTCH RECEPTOR; POLYMER; THIOCORALINE; ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; TUMOR MARKER;

ACHAETE SCUTE COMPLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOID; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR GROWTH; ANIMAL; DISEASE COURSE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CARCINOID TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; DEPSIPEPTIDES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84911479989     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2014.57     Document Type: Article

References (39)

1. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist 2008; 13: 1255-1269.
2. Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am 2006; 15: 463-478.
3. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340: 858-868.
4. Schnirer II, Yao JC, Ajani JA. Carcoinoid-a comprehensive review. Acta Oncol 2003; 42: 672-692.
5. Taal BG, Visser. O. Epidemiology of neuroendocrine tumours. Neuroendocrinology 2004; 80(Suppl 1): 3-7.
6. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959.
7. Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist 2007; 12: 535-542.
8. Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther 2002; 1: 466-476.
9. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999; 284: 770-776.
10. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Bio 2006; 7: 678-689.
11. Pérez Baz J, Cañedo LM, Fernández-Puentes JL, Silva Elipe MV. Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora. II. Physico-chemical properties and structure elucidation. J Antibiot 1997; 50: 738-741.
12. Romero F, Espliego F, Pérez Baz J, García de Quesada T, Grávalos D, De la Calle F et al. Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities. J Antibiot 1997; 50: 734-737.
13. Erba E, Bergamashi D, Ronzoni S, Faretta M, Taverna S, Bonfanti M et al. Mode of action of thiocoraline, a natural marine compound with anti-tumour activity. Brit J Cancer 1999; 80: 971-980.
14. Negri A, Marco E, García-Hernández V, Domingo A, Llamas-Saiz AL, Porto-Sandá S et al. Antitumor activity, X-ray crystal structure, and DNA binding properties of thiocoraline A, a natural bisintercalating thiodepsipeptide. J Med Chem 2007; 50: 3322-3333.
15. Wyche TP, Hou Y, Braun D, Cohen HC, Xiong MP, Bugni TS. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. J Org Chem 2011; 76: 6542-6547.
16. Tesfazghi S, Eide J, Dammalapati A, Korlesky C, Wyche TP, Bugni TS et al. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line. Cancer Med 2013; 2: 734-743.
17. Parkekh D, Ishizuka J, Townsend CM Jr, Haber B, Beauchamp RD, Karp G et al. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 1994; 9: 83-90.
18. Zarebczan B, Pinchot SN, Kunnimalaiyaan M, Chen H. Hesperetin, a potential therapy for carcinoid cancer. Am J Surg 2011; 201: 329-332.
19. Kunnimalaiyaan M, Yan S, Wong F, Zhang Y, Chen H. Hairy enhancer of split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. Surgery 2005; 138: 1137-1142.
20. Valentino JD, Li J, Zaytseva YY, Mustain WC, Elliot VA, Kim JT et al. Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res 2014; 20: 1212-1222.
21. Van Gompel JJ, Kunnimalaiyaan M, Holen K, Chen H. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther 2005; 4: 910-917.
22. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem 2006; 281: 39819-39830.
23. Jaskula-Sztul R, Pisarnturakit P, Landowski M, Chen H, Kunnimalaiyaan M. Expression of the active Notch1 decreases MTC tumor growth in vivo. J Surg Res 2011; 171: 23-27.
24. Vaccaro A, Chen H, Kunnimalaiyaan M. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer. Anticancer Drugs 2006; 17: 849-853.
25. Shin HC, Alani AW, Cho H, Bae Y, Kolesar JM, Kwon GS. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs. Mol Pharm 2011; 8: 1257-1265.
26. Chen H, Udelsman R, Zeiger M, Ball D. Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors. Oncol Rep 1997; 4: 775-778.
27. Oberg K, Janson ET, Eriksson B. Tumor markers in neuroendocrine tumours. Ital J Gastroenterol Hepatol 1999; 31(Suppl 1): S160-S162.
28. Mohammed TA, Holen KD, Jaskula-Sztul R, Mulkerin D, Lubner SJ, Schelman WR et al. A pilot Phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist 2011; 16: 835-843.
29. Faircloth G, Jimeno J, D'lncalci M. Biological activity of thiocoraline, a novel marine depsipeptide. Eur J Cancer 1997; 33: S175.
30. Boger DL, Ichikawa S. Total syntheses of thiocoraline and BE-22179: Establishment of relative and absolute stereochemistry. J Am Chem Soc 2000; 122: 2956-2957.
31. Boger DL, Ichikawa S, Tse WC, Hedrick MP, Jin Q. Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological properties. J Am Chem Soc 2001; 123: 561-568.
32. Tulla-Puche J, Góngora-Benítez M, Bayó-Puxan N, Francesch AM, Cuevas C, Albericio F. Enzyme-labile protecting groups for the synthesis of natural products: solid-phase synthesis of thiocoraline. Angew Chem Int Ed Engl 2013; 52: 5726-5730.
33. Lombó F, Velasco A, Castro A, de la Calle F, Braña AF, Sánchez-Puelles JM et al. Deciphering the biosynthesis pathway of the antitumor thiocoraline from a marine actinomycete and its expression in two Streptomyces species. Chembiochem 2006; 7: 366-376.
34. Sheoran A, King A, Velasco A, Pero JM, Garneau-Tsodikova S. Characterization of TioF, a tryptophan 2,3-dioxygenase involved in 3-hydroxyquinaldic acid formation during thiocoraline biosynthesis. Mol Biosyst 2008; 4: 622-628.
35. Robbel L, Hoyer KM, Marahiel MA. TioS T-TE-a prototypical thioesterase responsible for cyclodimerization of the quinoline-and quinoxaline-type class of chromodepsipeptides. FEBS J 2009; 276: 1641-1653.
36. Biswas T, Zolova OE, Lombó F, de la Calle F, Salas JA, Tsodikov OV et al. A new scaffold of an old protein fold ensures binding to the bisintercalator thiocoraline. J Mol Biol 2010; 397: 495-507.
37. Mady AS, Zolova OE, Lombó F, de la Calle F, Salas JA, Tsodikov OV et al. Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic cluster. Mol Biosyst 2011; 7: 1999-2011.
38. Lynge ME, Laursen MB, Hosta-Rigau L, Jensen BE, Ogaki R, Smith AA et al. Liposomes as drug deposits in multilayered polymer films. ACS Appl Mater Interfaces 2013; 5: 2967-2975.
39. Van der Westen R, Hosta-Rigau L, Sutherland DS, Goldie KN, Albericio F, Postma A et al. Myoblast cell interaction with polydopamine coated liposomes. Biointerphases 2012; 7: 1-9.